Basic Information
LncRNA/CircRNA Name | FEZF1-AS1 |
Synonyms | NR_036484 |
Region | GRCh38_7:122303658-122310077 |
Ensemble | ENSG00000230316 |
Refseq | NR_036484 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, Microarray, RNA-seq, Luciferase reporter assay, RIP, Western blot, etc. |
Sample | colorectal cancer tissues, cell lines (LoVo, Caco2, HT29, HCT8, HCT116, SW480) |
Expression Pattern | up-regulated |
Function Description | Increased FEZF1-AS1 expression is associated with poor survival. Functional assays revealed that FEZF1-AS1 promotes CRC cell proliferation and metastasis. FEZF1-AS1 could bind and increase the stability of the pyruvate kinase 2 (PKM2) protein, resulting in increased cytoplasmic and nuclear PKM2 levels. |
Pubmed ID | 29914894 |
Year | 2018 |
Title | LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling. |
External Links
Links for FEZF1-AS1 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |